The good news is that even a damaged liver retains an incredible ability to regenerate itself. The even better news is that herbs can help. Livup Liver Disorder Supplement is useful in infective hepatitis, fatty liver and other liver disorders. It increases the functional efficiency of liver.
| Packs |
Retail |
Shipping |
Order Now |
$50.00 |
 |
$75.00 |
|
$125.00 |
|
$250.00 |
|
|
Suggested usage: 1 Capsule twice daily after meals or as directed by the physician.
Livup Liver Disorder Supplement
• As an excellent liver tonic.
• As a liver care in chronic and occasional drinkers suffering with liver cirrhosis.
• Stimulates and increases the functional efficiency of liver, increases serum albumin.
• Useful in infective hepatitis.
• Helpful in enlarged or fatty liver.
• Other Liver Disorders.
|
Serving Size: 1 Capsule |
| |
|
|
|
250mg. |
** |
|
|
|
|
|
|
|
|
|
** Daily value not established |
|
Suggested usage: 1 Capsule twice daily after meals or as directed by the physician.
|
Herbal therapy has been an important part of health and wellness for hundreds of years.
Phyllanthus amarus (Bhumyaamalaki):
Phyllanthus has been used in Ayurvedic medicine for over 2,000 years and has a wide number of traditional uses. Phyllanthus blocks DNA polymerase, the enzyme needed for the hepatitis B virus to reproduce. Fifty-nine percent of those infected with chronic viral hepatitis B lost one of the major blood markers of HBV infection (e.g., hepatitis B surface antigen) after using phyllanthus for thirty days. (1,2)
The Phyllanthus genus encompasses more than 600 species, found throughout the tropics and subtropics, including central and southern India
Efficacy of Phyllanthus amarus treatment in acute viral hepatitis A, B and non A non B: an open clinical trial.
Authors: Jayaram, S; Thyagarajan, SP; Sumathi, S; Manjula, S; Malathi, S; & Madanagopalan, N
BIBLIOGRAPHIC CITATION Indian-Journal-of-Virology. 1997, 13: 1, 59-64; 12 references
The efficacy of an Indian medicinal plant, P. amarus to treat acute viral hepatitis (AVH) was evaluated in parallel with another drug Essentiale (an essential phospholipid extracted from soyabean oil) and compared with a group of patients who were treated symptomatically with vitamins as the control. Serological profile of 93 sporadic AVH cases of the study showed that 25.8% had an acute infection due to hepatitis A virus (HAV), 52.6% suffered due to hepatitis B viral (HBV) infection, while 19.3% of cases were classified as non-A non-B hepatitis (NANB) by exclusion. On follow-up of the patients at the end of treatment period of 4 weeks with each respective drug regimen, it was seen that both P. amarus and Essentiale brought about significant biochemical and clinical normalcy among the HAV infected patients compared with the control group. In acute HBV group, P. amarus-treated patients recovered faster than the Essentiale-treated group and the controls. Essentiale helped the non-A non-B hepatitis patients to resume biochemical normalcy earlier than the other treatments. It was suggested that P. amarus seemed to accelerate the clearance of hepatitis B surface antigen in 86.9% of convalescing AVH-B cases after 3 months time as against 48.0% in the Essentiale treated group and 50% in the controls.
Picrorhiza kurroa (Hellbore, Kutki):
In Ayurveda Picrorhiza kurroa is a reputed remedy for the treatment of liver diseases. The chemical composition of the Picrorhiza has been studied and active constituents are group of iridoid glycosides known as picrosides and kutkosides. Modern clinical studies have confirmed the efficacy and safety of Picrorhiza kurroa for the treatment of liver disease (3)
J Gastroenterol Hepatol. 2002 Dec;17 Suppl 3:S370-S376.
Herbal medicines for liver diseases in India.
Thyagarajan S, Jayaram S, Gopalakrishnan V, Hari R, Jeyakumar P, Sripathi M.
The use of natural remedies for the treatment of liver diseases has a long history, starting with the Ayurvedic treatment, and extending to the Chinese, European and other systems of traditional medicines. The 21st century has seen a paradigm shift towards therapeutic evaluation of herbal products in liver diseases by carefully synergizing the strengths of the traditional systems of medicine with that of the modern concept of evidence-based medicinal evaluation, standardization of herbal products and randomized placebo controlled clinical trials to support clinical efficacy. The present review provides the status report on the scientific approaches made to herbal preparations used in Indian systems of medicine for the treatment of liver diseases. In spite of the availability of more than 300 preparations for the treatment of jaundice and chronic liver diseases in Indian systems of medicine using more than 87 Indian medicinal plants, only four terrestrial plants have been scientifically elucidated while adhering to the internationally acceptable scientific protocols. In-depth studies have proved Sylibum marianum to be anti-oxidative, antilipidperoxidative, antifibrotic, anti-inflammatory, immunomodulating and liver regenerative. Glycyrrhiza glabra has been shown to be hepatoprotective and capable of inducing an indigenous interferon. Picrorhiza kurroa is proved to be anti-inflammatory, hepatoprotective and immunomodulatory. Extensive studies on Phyllanthus amarus have confirmed this plant preparation as being anti-viral against hepatitis B and C viruses, hepatoprotective and immunomodulating, as well as possessing anti-inflammatory properties. For the first time in the Indian systems of medicine, a chemo-biological fingerprinting methodology for standardization of P. amarus preparation has been patented.
Andrographis paniculata (The Creat, Kalmegh):
Andrographis paniculata Nees (Acanthaceae), the Kalmegh of Ayurveda is an erect annual herb extremely bitter in taste in each and every part of the plant body. The plant is known in north-eastern India as ‘Maha-tita’, literally ‘king of bitters’
The major constituents in andrographis are diterpene lactones known as andrographolides. These bitter constituents are believed to have immune-stimulating, anti-inflammatory, fertility-decreasing, liver-protective, and bile secretion-stimulating actions. (4)
Glycyrhhiza (licorice):
One of the active constituents in licorice, glycyrrhizin, is sometimes used in Japan as an injected therapy for hepatitis B and C (5,6)
It has been shown to have a direct hepatoprotective effect. Glycyrhhiza flavonoids provide protection to hepatocytes exposed to carbon tetrachloride and galactosamine. Research points to the antilipid peroxidation effect of glycyrrhiza as the central mechanism contributing to its protective action against carbon tetrachloride-induced hepatotoxicity. Glycyrrhiza has also been shown to significantly quench free radicals. Recent studies have shown glycyrrhiza to enhance the detoxification of medications and toxins. Several mechanisms seem to be involved, one of which is increased liver glucuronidation. Glycyrrhiza exerts antiviral activity in vitro toward a number of viruses, including hepatitis A, varicella zoster, HIV, herpes simplex type 1, Newcastle disease, and vesicular stomatitis viruses. Intravenous glycyrrhizin has been shown to be effective in a double blind study against viral hepatitis, chronic viral hepatitis in particular. Administered in a physiologic saline solution in combination with cysteine and glycine (a product called Stronger Neo Minophagen-C, or SNMC), glycyrrhiza has been shown to stimulate endogenous interferon production in addition to its antioxidant and detoxifying effects.
1) Thyagarajan SP, Subramanian S, Thirunalasundar T, et al. Effect of Phyllanthus amarus on chronic carriers of hepatitis B virus. Lancet 1988: ii: pp.764-6
2) Meixa W, Haowei C, Yanjin L, et al. Herbs of the genus Phyllanthus in the treatment of chronic hepatitis B: observation with three preparations from different geographic sites. J Lab Clin Med 1995;126: pp.350-2
3) Luper S. (1998) A review of plants used in the treatment of liver disease: part
Southwest College of Naturopathic Medicine: 2140 East Broadway Rd. Tempe, AZ 85282, USA. Altern Med Rev. Dec; 3(6): 410-21.
4) Chaturvedi GN, Tomar GS, Tiwari SK, Singh KP. Clinical studies on kalmegh (Andrographis paniculata) in infective hepatitis. J Int Inst Ayurveda 1983;2:208–11.
5) Suzuki H, Ohta Y, Takino T, et al. Effects of glycyrrhizin on biochemical tests in patients with chronic hepatitis. Double blind trial. Asian Med J 1983;26:423–38.
6) Yasuda K, Hino K, Fujioka S, et al. Effects of high dose therapy with Stronger Neo-Minophagen C (SNMC) on hepatic histography in non-A, non-B chronic active hepatitis. In Viral Hepatitis C, D, E, ed. T Shikata, RH Purcell, T Uchida. Amsterdam: Excerpta Medica, 1991, 205–9.
|
MY CART 
CHECKOUT
